M&A Deal Summary

Sanofi Acquires TargeGen

On June 30, 2010, Sanofi acquired life science company TargeGen from Chicago Growth Partners for 635M USD

Acquisition Highlights
  • This is Sanofi’s 5th transaction in the Life Science sector.
  • This is Sanofi’s 8th largest (disclosed) transaction.
  • This is Sanofi’s 5th transaction in the United States.
  • This is Sanofi’s 2nd transaction in California.

M&A Deal Summary

Date 2010-06-30
Target TargeGen
Sector Life Science
Buyer(s) Sanofi
Sellers(s) Chicago Growth Partners
Deal Type Add-on Acquisition
Deal Value 635M USD
Advisor(s) Solomon Partners (Financial)

Target

TargeGen

San Diego, California, United States
website
TargeGen, Inc., a biopharmaceutical company focusing on treatments for cardiovascular (ischemic) diseases and cancer.

Search 190,634 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sanofi

Paris, France

website


Category Company
Founded 1994
Sector Life Science
Employees99,412
Revenue 45.4B EUR (2022)
DESCRIPTION

Sanofi is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi was founded in 1994 and is based in Paris, France.


DEAL STATS #
Overall 12 of 27
Sector (Life Science) 5 of 18
Type (Add-on Acquisition) 8 of 21
State (California) 2 of 5
Country (United States) 5 of 16
Year (2010) 3 of 4
Size (of disclosed) 8 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-18 Zentiva

Prague, Czech Republic

Zentiva is a generics pharmaceutical company, offering generic medicines across all key therapeutic areas. Zentiva is headquartered in Prague, Czech Republic.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-09-27 VaxDesign

Orlando, Florida, United States

VaxDesign is a privately held U.S. biotechnology company, based in Orlando, Florida, that develops, manufactures and markets in vitro models of the human immune system. VaxDesign is the developer of the Modular IMmune In-vitro Construct (MIMIC®) technology that meldsimmunology with engineering to find solutions to complex biological problems.

Buy -

Seller(S) 1

SELLER

Chicago Growth Partners

Chicago, Illinois, United States

website


Category Growth Capital Firm
Founded 2004
PE ASSETS 1.2B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Chicago Growth Partners LLC (CGP) was a Chicago-based based private equity firm that provided expansion and buyout capital to middle-market companies generating sales of $15 to $150 million. CGP sought to invest in business services, consumer services, healthcare products/services, and industrial companies. CGP was formed in 2004 as a spin-off of William Blair Capital Partners, the investment group of investment bank William Blair. In 2014, the Firm ceased operations.


DEAL STATS #
Overall 16 of 34
Sector (Life Science) 4 of 6
Type (Add-on Acquisition) 8 of 15
State (California) 5 of 10
Country (United States) 14 of 31
Year (2010) 1 of 2
Size (of disclosed) 1 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-12-07 Zogenix

Emeryville, California, United States

Zogenix is a pharmaceutical company focused on the development and commercialization of medicines to treat neuroscience disorders and pain. Zogenix was founded in 2006 and is based in Emeryville, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-09-30 SchoolMessenger

Los Gatos, California, United States

SchoolMessenger is a provider of on-demand, mass notification software solutions for the education market. Mass notification, a growing industry, is used in a variety of situations to keep people informed through multiple message delivery channels including phone calls, emails and text messages.

Buy -